Our Machine Learning Internship is designed for curious, ambitious researchers who want to apply machine learning to complex, real-world problems. Over 10 weeks, youll work alongside experienced researchers and mentors to develop models, analyze large-scale datasets,
Mitek (NASDAQ: MITK) is a global leader in digital & biometric identity authentication, fraud prevention, and mobile deposit solutions. Our verified identity platform and advanced image capture solutions are built on the latest advancements in biometric recognition, artificial
An Amazing Career Opportunity for a Pre Sales Consultant Benelux! Location: Veldhoven, Netherlands Job ID: 48987 This role will be a part of the PACS business which is highly visible and one of our most significant
Overview Working at Atlassian Atlassians can choose where they work – whether in an office, from home, or a combination of the two. That way, Atlassians have more control over supporting their family, personal goals, and
Overview Working at Atlassian Atlassians can choose where they work – whether in an office, from home, or a combination of the two. That way, Atlassians have more control over supporting their family, personal goals, and
Klantenservice Medewerker Claims / Customer Service Claims Associate (Dutch Speaker) Amsterdam | Hybrid Working – 2 days office, 3 days home Help customers get back to what matters most. Do you enjoy helping people, solving problems,
Customer Service Associate- German Speaker Amsterdam Overview of Position As a member of our European Claims team, your main responsibility will be to assess and resolve insurance claims. We are seeking candidates who have an excellent
Advanced Cyber Defense Practice Lead The Opportunity: Guide modern SOC, Cyber Fusion Center, and detection and response transformation initiatives for large multinational enterprises across select international regions. Shape and deliver Booz Allen’s advanced cyber defense capabilities,
Company Overview We are partnering with a late-stage biopharmaceutical company developing a first-in-class therapy for cardio-metabolic disease, targeting the intersection of metabolic dysfunction and cardiovascular risk. With its lead asset advancing into Phase 3 development, the
We are partnering with a late-stage biopharmaceutical company developing a first-in-class therapy for cardio-metabolic disease, targeting the intersection of metabolic dysfunction and cardiovascular risk. With its lead asset advancing into Phase 3 development, the organisation is